Cytokinetics ceo
WebOct 22, 2024 · Robert Blum became the CEO of Cytokinetics, Incorporated ( NASDAQ:CYTK) in 2007, and we think it's a good time to look at the executive's … WebMar 2, 2024 · SOUTH SAN FRANCISCO, CA, Feb 05, 2008 (MARKET WIRE via COMTEX News Network) -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the BIO CEO and Investor Conference at the Waldorf Astoria Hotel in New …
Cytokinetics ceo
Did you know?
WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate WebNov 18, 2024 · Based on our data team's research, Robert I. Blum is the Cytokinetics's CEO. Cytokinetics has 130 employees, of which 42 are in a leadership position. Here are …
WebCytokinetics. We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and … WebMar 31, 2024 · Cytokinetics Diane Weiser Senior Vice President, Corporate Communications, Investor Relations (415) 290-7757 Source: Cytokinetics, Incorporated …
WebMar 31, 2024 · The company in the coming months will assess measures needed for the development of its neuromuscular pipeline, Cytokinetics CEO Robert Blum said in a statement. ALS, also known as Lou Gehrig’s disease, breaks down nerve cells in the brain and spinal cord that make muscles work, leading to progressive paralysis and death. WebApr 13, 2024 · In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the company’s stock in a transaction on Tuesday, March 28th. The stock was sold at an average price of $35.05, for a total transaction of $438,125.00. Following the completion of the sale, the chief executive officer now owns 441,058 shares in the company, valued at ...
WebFeb 28, 2024 · FDA rejects Cytokinetics’ heart failure drug. The decision comes two months after outside advisers voted 8 to 3 that the risks of the drug, omecamtiv mecarbil, outweigh its benefits. The exterior of the Food and Drug Administration headquarters is seen on July 20, 2024 in White Oak, Maryland. Sarah Silbiger via Getty Images.
WebMar 31, 2024 · SOUTH SAN FRANCISCO, Calif., March 31, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Data Monitoring Committee (DMC) for COURAGE-ALS ( C linical O ... share distribution listsWebMar 31, 2024 · Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis. Cytokinetics to Host Conference Call and Webcast Today at 8:30 am Eastern Time. SOUTH SAN FRANCISCO, Calif., March 31, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Data Monitoring … shared issuesWebJan 10, 2024 · Cytokinetics’ CEO, Robert I. Blum, commented, “These corporate development transactions continue our history of monetizing our leadership in muscle biology through creative deal making and ... share display over wifiWebMar 31, 2024 · The company in the coming months will assess measures needed for the development of its neuromuscular pipeline, Cytokinetics CEO Robert Blum said in a statement. pool supermarket o\u0027halloran hillWebMay 7, 2024 · Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ETCompany ParticipantsDiane Weiser – Senior Vice President-Corporate Communications and... pool sun ledge loungersWebFeb 21, 2024 · The estimated net worth of Robert I. Blum is at least $17.05 million as of January 17th, 2024. Mr. Blum owns 406,412 shares of Cytokinetics stock worth more than $17,048,983 as of March 4th. This net worth evaluation does not reflect any other investments that Mr. Blum may own. Learn More about Robert I. Blum's net worth. shareditemWebMar 31, 2024 · Cytokinetics to Host Conference Call and Webcast Today at 8:30 am Eastern Time. SOUTH SAN FRANCISCO, Calif., March 31, ... Cytokinetics’ CEO and … share distribution list in outlook office 365